Dr. Kristin Leslie Ratliff, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 360 Brockton Ave, Abington, MA 02351 Phone: 781-878-1701 Fax: 781-878-4375 |
News Archive
Avastin (bevacizumab), Roche's innovative anti-cancer drug, was approved today in Europe for the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC), in combination with platinum-based chemotherapy.
Cancer cells that can break out of a tumor and invade other organs are more aggressive and nimble than nonmalignant cells, according to a new multi-institutional nationwide study.
ViroPharma Incorporated today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion at its plenary meeting in March 2011 recommending approval of a Centralized Marketing Authorization for Cinryze (C1 inhibitor [human]) in adults and adolescents with hereditary angioedema for routine prevention, pre-procedure prevention and acute treatment of angioedema attacks.
Congress's bipartisan super committee is heading toward its November 23 deadline with no deal in sight to cut $1.2 trillion from the deficit over 10 years. So it's time to think seriously about the consequences of the default alternative, which would be a $1.2 trillion "sequester," or automatic spending cut, starting in 2013. It's hardly the nightmare of Washington dread.
High-tech, digital mammography may not be any better at detecting breast cancer in women over 65 than older film-based systems, but Medicare is spending millions of taxpayer dollars reimbursing the procedure at a far higher rate. A new study comparing digital mammography with less expensive film mammography found that the two types of breast cancer screens are equally effective at detecting cancers in most women. ... The study was performed by the National Cancer Institute-funded Breast Cancer Surveillance Consortium.
› Verified 4 days ago